Clinical trial NCT01527955: Kelee® Meditation: A Distinctive and Effective Therapeutic Intervention for Stress, Anxiety, and Depression
Official title: Troubleshooting the Mind Through Kelee® Meditation: A Distinctive and Effective Therapeutic Intervention for Stress, Anxiety, and Depression
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Stress
Anxiety
Depression
Keywords: Kelee
Meditation
Stress
Anxiety
Depression
Brain
Mind
Lead sponsor: University of California, San Diego
Sponsor class: OTHER
First posted: 2012-02-07
Enrollment: 47
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: The purpose of this study is to determine how effective Kelee meditation is in improving stress, anxiety, and depression.

Detailed description: The Kelee and Kelee meditation (KM) were developed and founded by Ron W. Rathbun. KM is a unique and distinctive form of meditation that is easy to learn and requires only about 10 minutes twice a day to perform. The goal and discipline of KM is the development of one-pointed stillness of mind. To better comprehend how KM is effective in reducing stress, anxiety, and depression, one must understand the difference between concentration and meditation, and the basic principles of the Kelee. Experiencing and understanding the distinction between brain function and mind function are of vital importance in KM. Brain function is associated with the tension-based, intellectual, thinking process and the five physical senses whereas mind function is associated with the relaxation-based, experiential, mental feeling process, self-awareness, and clear perception. Performing KM leads to the calming of brain function and opening to the experience of mind function. With continued practice, persistence, and patience, the practitioner can begin to learn on his own how to examine and understand (ie, troubleshoot) his own thoughts and feelings from a calm, clear internal space that is free from the negative chatter and preconception associated with the brain. This increases self-awareness of the presence of internalized compartments (misperceptions of life that exist as negative thoughts and/or feelings) and the practitioner begins to develop clarity of perception. Clear perception allows one to begin the process of detachment from internalized compartments, which occurs through the cessation of looping followed by the processing of compartments. As each negative compartment dissipates, the practitioner experiences a subtle, but cumulative, corresponding improvement in stress, anxiety, and depression. When the flow of the Kelee is allowed to be, there is balance between the thinking and the feeling process leading to overall well-being, which leads to improved self-efficacy and reinforces the repetition of KM.

Eligibility criteria: Inclusion Criteria:

* Documented HIV-1 infection
* Ages 18 to 65
* Experiencing some level of stress, anxiety, or depression
* No current use of other meditation practices or holistic modalities

Exclusion Criteria:

* Non-English readers or speakers
* Hearing-impaired
* Low literacy below 5th grade reading and comprehension level

Primary outcomes:
measure: Change in Total Score of Depression, Anxiety, and Stress Scales-42 (DASS-42)
timeFrame: From Week 0 (baseline) to Week 12
Secondary outcomes:
measure: Change in Depression Subscale Score of DASS-42
timeFrame: From Week 0 (baseline) to Week 12
measure: Change in Anxiety Subscale Score of DASS-42
timeFrame: From Week 0 (baseline) to Week 12
measure: Change in Stress Subscale Score of DASS-42
timeFrame: From Week 0 (baseline) to Week 12
measure: Change in Total Score of Beck Depression Inventory-II (BDI-II)
timeFrame: From Week 0 (baseline) to Week 12
measure: Change in Total Score of Beck Anxiety Inventory (BAI)
timeFrame: From Week 0 (baseline) to Week 12
measure: Change in Total Score of Perceived Stress Scale-10 (PSS-10)
timeFrame: From Week 0 (baseline) to Week 12
measure: Change in Global Severity Index (GSI) of the Symptom Checklist-90-Revised (SCL-90-R)
timeFrame: From Week 0 (baseline) to Week 12
measure: Change in Mental Component Summary (MCS) of the Short Form-36 Health Survey (SF-36)
timeFrame: From Week 0 (baseline) to Week 12
Other outcomes:
Locations:
city: San Diego
country: United States
facility: Being Alive San Diego
state: California
city: San Diego
country: United States
facility: University of California, San Diego Medical Center
state: California
Study officials:
affiliation: University of California, San Diego
name: Daniel Lee, MD
role: PRINCIPAL_INVESTIGATOR
References: